As has been shown in mouse models, TF-targeting with fVII-conjugated photosensitizers has the potential to significantly improve the selectivity and efficacy of PDT for the treatment of breast and lung cancer [15, 18–20]. The gene discussed is TF; the disease is lung carcinoma.